Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 study evaluating low-dose fludarabine, busulfan, and anti-thymocyte globulin conditioning followed by donor umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on allogeneic transplantation using total lymphoid irradiation and anti-thymocyte globulin in older patients w…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase I/II trial of Brentuximab in combination with 5-azacytidine for leukemia was terminated; results posted in 2017.
-
CLINICAL_TRIALS research · 2017-08-30Clinical Trial Update: Expression of TET1 Gene in Acute Leukaemia
This document reports on a clinical trial investigating the expression of the TET1 gene in patients with acute leukemia.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy followed by unrelated donor stem cell transplantation for blood and immune system cancers; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study of oral LBH589 (panobinostat) in adults with advanced hematologic malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial evaluating CD19-specific T-cell therapy for Chronic Lymphocytic Leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells [Phase 1]
A Phase 1 study evaluating infusion of allogeneic cord blood-derived CD19-specific T cells for leukemia and lymphoma has completed.
-
CLINICAL_TRIALS research · 2017-07-31Clinical Trial Update: Laboratory Studies Into the Pathology of Leukaemia
This entry describes laboratory studies investigating the pathology of leukemia conducted by the Royal Marsden NHS Foundation Trust. The tri…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Phase 1 trial of Recombinant Human Arginase 1 (rhArg1) in relapsed or refractory leukemia or lymphoma has been terminated. This status updat…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors [Phase 1, Phase 2]
Early-phase clinical trial evaluating haploidentical transplant with NK cell infusion for pediatric leukemia and solid tumors; study termina…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]
A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across m…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS guidance · 2017-07-02Clinical Trial Update: Informed Consent in Pediatric Cancer Trials
NCI provides guidance on informed consent practices for pediatric cancer clinical trials, highlighting considerations to protect children an…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
This news update reports on completed pilot studies assessing clinical, laboratory, and epidemiologic aspects in people at high risk for vir…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Pharmacokinetic Studies Participation Survey
This completed NCI-sponsored trial update covers participation in pharmacokinetic studies for patients with relapsed solid tumors and leukem…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
-
CLINICAL_TRIALS research · 2017-06-27Clinical Trial Update: Collection of Patient-Reported Symptoms and Performance Status Via the Internet [NA]
This is a completed clinical trial update describing online collection of patient-reported symptoms and performance status across multiple c…
-
CLINICAL_TRIALS research · 2017-06-22Clinical Trial Update: Improving Patient Education for Lymphoma and Leukemia Inpatients [NA]
A completed clinical trial conducted by Emory University aimed at improving education for inpatients with leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease [Phase 2]
Phase 2 trial update describing donor umbilical cord blood transplantation for advanced hematologic cancers, including leukemia, lymphoma, m…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR [NA]
A completed clinical trial investigates improving adherence to oral cancer agents and self-care of symptoms using an IVR system, sponsored b…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT [Phase 2]
Phase 2 trial of sirolimus and mycophenolate mofetil as graft-versus-host disease prophylaxis in myeloablative, matched related donor hemato…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…